The FDA has approved revumenib (Revuforj; Syndax Pharmaceuticals) for patients aged 1 year and older with relapsed or ...

Elinzanetant provides a hormone-free treatment option for vasomotor symptoms by targeting the brain's thermoregulatory center ...

Craig See, MD, a cornea specialist for the Cole Eye Institute at Cleveland Clinic, emphasized that cornea injuries are ...

Multigene next-generation sequencing (NGS) performed directly on tumor tissue can accurately identify pathogenic variants in epithelial ovarian cancer (EOC), detecting both somatic and germline ...

Extreme temperatures were found to exacerbate cardiovascular mortality in older patients with heart failure (HF), according to a new research letter published in JAMA Cardiology. 1 As human biology ...

US safety data show that elinzanetant caused few adverse events and no new liver-related concerns in women, James Simon, MD, explains. Nonhormonal treatment options for vasomotor symptoms continue to ...

Researchers have found that using mobile-app–based surveys and photography to remotely track and assess atopic dermatitis (AD ...

Breast cancer is the most-researched disease, yet only 14% of trials reach optimal enrollment, highlighting a significant gap in clinical trial participation. COVID-19 has increased trial attrition ...

Liver Awareness Month, observed each October, increases public understanding of the causes, symptoms, and outcomes of liver disease and highlights steps that can be taken at both the individual and ...

Belantamab mafodotin provides a community-friendly BCMA-directed therapy option for relapsed/refractory myeloma, says Hearn ...

Consolidative radiotherapy (RT) can improve outcomes in patients with diffuse large B-cell lymphoma (DLBCL), according to a ...

Menopause comes with more symptoms than just hot flashes—many women experience major shifts in body composition that can influence long-term health. These changes are different from those seen with ...